Isländsk genetikpionjär får Fernströms nordiska pris

En av världens mest kända forskare inom populationsgenetik, professor Kári Stefánsson från Island, tilldelas Eric K Fernström nordiska pris.

Ancient DNA provides new insights – “The immune system lost its job”

Ancient bone remains from our ancestors have provided new insights into the prevalence of multiple sclerosis. By looking back in time, researchers can provide a...

Total pipeline of pharmaceutical companies reaches a record high – 22,921 medicines are currently being developed

Despite the difficult economic times, pharmaceutical companies have never developed as many new drugs as now.

Kvinnan bakom Novo Nordisks fetmasuccé: ”Slutade aldrig tro på GLP-1”

Det tog flera år av misslyckanden inom GLP-1 innan Lotte Bjerre Knudsen och hennes kollegor hittade rätt – men då var det en riktig fullträff. ”Vi investerade i...

New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Stockholm (2026)

An easy way to handle microtiter plate stacks

Do you want to automate handling of microtiter plates.? Have a look at a very simple solution on how to handle them.

Quotient Sciences Limited

Nocebo – the evil twin that makes you feel worse

The placebo effect is well known in healthcare, but not so its opposite: nocebo. “The effect is small, but it can have major repercussions,” says Uppsala resear...

“Conducting research at universities is becoming more and more like working at a research hotel”

The government wants Swedish research to focus on excellence and innovation, but can the two be combined? Life Science Sweden talks to Anna Falk, a professor at...

ZEISS Microscope has been Optimized for Capturing Subcellular Structures and their Dynamics

Live imaging with uniform super-resolution in all spatial dimensions.

Bio Europe to Stockholm – ”The Swedish ecosystem is now taking the opportunity”

The international life science conference Bio Europe is coming to Sweden for the first time in November. The conference, whose program takes inspiration from AB...

Affibody AB

Astra Zeneca's Covid-19 vaccine Vaxzevria is being withdrawn worldwide

AstraZeneca initiates a worldwide withdrawal of its Covid vaccine Vaxzevria. The measure is taken just months after the company admitted the vaccine can cause a...

Eternal Rye – Improving Plant Breeding Methods

User story from Martin Luther University Halle.

A green nursery for biotech rooted in the Scanian soil

Red Glead has established itself as one of Lund’s largest companies in pharmaceutical development. Life Science Sweden went to Skåne and met two of the founders...

Pressen att publicera göder rovtidskrifterna

Forskare som lockas, eller luras, att publicera sig i tvivelaktiga vetenskapliga tidskrifter är ett fenomen som vuxit. Men vad är egentligen en rovtidskrift, oc...

3 avgörande faktorer vid valet av nytt affärssystem

Att investera i ett ERP-system innebär att navigera genom en mängd frågor och alternativ. En av de största utmaningarna är att hitta rätt lösning för ert företa...

Hon ska leda Lipigons kliniska prövningar

Umeåbolaget Lipigon Pharmaceuticals har anställt Isabelle Morin som Head of Clinical Operations.

Learn from Speakers from Leading MedTech Companies

Watch the recordings from ZEISS Quality Innovation Days whenever it suits you.

”We need compatibility“

Penilla Gunther, founder of Fokus Patient and chair of the European Patient Safety Foundation, hopes that the forthcoming life science strategy will focus on ef...

Lucy Robertshaw: Did you know Stockholm wants to be in top 5 in the world for Life Sciences?

Karolinska Institutet Solna Campus has certainly become the next “Kendall Square”, writes Lucy Robertshaw in a column.

QPS Netherlands B.V

Sobi planerar EMA-ansökan efter positiva studiedata för njurbehandling

Det svenska särläkemedelsbolaget Sobi rapporterar positiva resultat från en fas III-studie med företagets läkemedelskandidat pegcetacoplan mot två sällsynta nju...

Samuel Lagercrantz: ”Geoffrey Hintons farhågor”

”Ska vi få en så ljus framtid som möjligt där AI används på bästa sätt behövs både de som ser risker med den nya tekniken och de som ser sig som teknikoptimiste...